Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Francis

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|September 1, 1989
The modulation by chlormethiazole of the GABAA-receptor complex in rat brainA J Cross, J M Stirling, T N Robinson, et al.
Experimental Neurology|September 19, 1997
Neuronal degeneration by suicide transport following injection of volkensin into rat cerebral cortexP R Heath, I P Chessell, M W Sanders, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensinP T Francis, M N Pangalos, R C Pearson, et al.
Brain : a Journal of Neurology|August 1, 1988
Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's diseaseS L Lowe, P T Francis, A W Procter, et al.
Brain Research|November 20, 1992
NMDA receptors assessed by autoradiography with [3H]L-689,560 are present but not enriched on corticofugal-projecting pyramidal neuronesM N Pangalos, P T Francis, A C Foster, et al.
Annales De Medecine Interne|January 1, 1990
Clinical correlations of the neurobiological changes of agingA W Procter, P T Francis, S L Lowe, et al.
Neurobiology of Aging|September 1, 1989
Pyramidal neuron loss and "glycine-site therapy": a need for an animal model and study in late-life depressionD M Bowen, P T Francis, S L Lowe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 23, 2003
Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's diseaseM Garcia-Alloza, W D Hirst, C P L-H Chen, et al.
Neurology|September 12, 2001
Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortexM K Lai, O F Lai, J Keene, et al.
Neurochemistry International|July 13, 2019
Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementiaE Clarke, C Jantrachotechatchawan, Y Buhidma, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|September 1, 1989
The modulation by chlormethiazole of the GABAA-receptor complex in rat brainA J Cross, J M Stirling, T N Robinson, et al.
Experimental Neurology|September 19, 1997
Neuronal degeneration by suicide transport following injection of volkensin into rat cerebral cortexP R Heath, I P Chessell, M W Sanders, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensinP T Francis, M N Pangalos, R C Pearson, et al.
Brain : a Journal of Neurology|August 1, 1988
Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's diseaseS L Lowe, P T Francis, A W Procter, et al.
Brain Research|November 20, 1992
NMDA receptors assessed by autoradiography with [3H]L-689,560 are present but not enriched on corticofugal-projecting pyramidal neuronesM N Pangalos, P T Francis, A C Foster, et al.
Annales De Medecine Interne|January 1, 1990
Clinical correlations of the neurobiological changes of agingA W Procter, P T Francis, S L Lowe, et al.
Neurobiology of Aging|September 1, 1989
Pyramidal neuron loss and "glycine-site therapy": a need for an animal model and study in late-life depressionD M Bowen, P T Francis, S L Lowe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 23, 2003
Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's diseaseM Garcia-Alloza, W D Hirst, C P L-H Chen, et al.
Neurology|September 12, 2001
Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortexM K Lai, O F Lai, J Keene, et al.
Neurochemistry International|July 13, 2019
Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementiaE Clarke, C Jantrachotechatchawan, Y Buhidma, et al.
Pageof 8